The FDA approved Eli Lilly’s Jardiance to reduce the risk of cardiovascular death and hospitalization for heart failure in adults, the agency said Feb. 24.
Read the full post on Becker's Hospital Review - Healthcare News
Read the full post on Becker's Hospital Review - Healthcare News